Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GRI | Common Stock | Purchase | $41.2K | +10.7K | $3.85 | 10.7K | May 25, 2021 | Direct | ||
transaction | GRI | Common Stock | Purchase | $30.6K | +6.8K | +63.55% | $4.50 | 17.5K | May 26, 2021 | Direct | |
holding | GRI | Common Stock | 844K | May 25, 2021 | By Arcturus Therapeutics, Inc. | F1 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |